Influenza A virus vaccine H5N2 intranasal (BioDiem)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus vaccine H5N2 intranasal (BioDiem)
Drug Alias NamePandemic LAIV H5N2LAIV H5N2/A/Len/17GPO H5N2 PLAIVGPO Avian Flu VaccineLAIV H5N2 pandemic vaccine +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Experimental Medicine Of The Russian Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Experimental Medicine, Russia
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB
Related LinksN/A